U.S. Interactive Media and Services Stock News

NYSE:NET
NYSE:NETIT

Cloudflare Deepens Security Role With Post Quantum SASE And Mastercard Pact

Cloudflare launched what it calls the first complete Secure Access Service Edge platform with post-quantum encryption across its services. The company also announced a cybersecurity partnership with Mastercard aimed at protecting critical infrastructure and small businesses with real time, risk driven defenses. Cloudflare, trading on the NYSE under ticker NYSE:NET, sits at the intersection of networking and security. This move pushes more of its product stack into the security spotlight...
NYSE:MHK
NYSE:MHKConsumer Durables

Mohawk Industries Weighs Latin America Growth Against Legal And Cost Pressures

Mohawk Industries (NYSE:MHK) has outlined a refreshed expansion and risk profile in its latest 10-K and internal SWOT analysis. The company is pursuing growth in Brazil and Mexico through acquisitions alongside investment in additional manufacturing capacity. Management is putting more emphasis on sustainability and operational efficiency while addressing legal exposures tied to PFAS and silica dust regulations. For investors watching the flooring and surfaces space, Mohawk Industries sits...
NYSE:MUR
NYSE:MUROil and Gas

Murphy Oil Weighs Côte D'Ivoire Dry Wells Against Future Exploration Upside

Murphy Oil, NYSE:MUR, reported two consecutive dry wells in its offshore Côte d'Ivoire exploration campaign. The company is abandoning the Caracal-1X well after non commercial results. Despite these outcomes, Murphy Oil plans to proceed with drilling a third well, Bubale-1X, in a different geological structure. For investors tracking NYSE:MUR, this update comes with the stock at $33.15 and a 1 year return of 31.6%, alongside a 5 year return of 95.6%. At the same time, the stock shows mixed...
NYSE:VST
NYSE:VSTRenewable Energy

Vistra (VST) Margin Compression To 4.2% Tests Bullish Earnings Expansion Narrative

Vistra (VST) has wrapped up FY 2025 with Q4 revenue of US$4.6b, Basic EPS of US$0.55, and net income of US$185m, while trailing twelve month figures show revenue of US$17.7b and Basic EPS of US$2.23 anchored by net income of US$752m. The company has seen quarterly revenue range from US$3.9b to US$5.0b across 2025, with Basic EPS swinging from a Q1 loss of US$0.93 to a Q3 figure of US$1.78. This sets up a results picture where investors are likely to focus on how those earnings translate into...
NasdaqGS:WFRD
NasdaqGS:WFRDEnergy Services

Is It Too Late To Consider Weatherford International (WFRD) After Its Strong Multi Year Rally

If you are wondering whether Weatherford International is still offering value at its current price, this overview will help you frame what the market might be pricing in today. The stock last closed at US$105.46, with returns of 1.0% over 7 days, 15.3% over 30 days, 30.4% year to date and 73.1% over 1 year. The 3 year return is 56.9% and the 5 year return is very large at around 7x. Recent coverage of Weatherford International has focused on its role in the energy sector and how investors...
NYSE:PRMB
NYSE:PRMBBeverage

Primo Brands (PRMB) Q4 Loss Tests Bullish Margin Expansion Narrative

Primo Brands (PRMB) closed FY 2025 with Q4 revenue of US$1.6b and basic EPS of a US$0.07 loss, capping off a trailing twelve month period where revenue reached US$6.7b and EPS came in at US$0.22. Over recent quarters, the company has seen revenue range from US$1.4b in Q4 FY 2024 to US$1.8b in Q3 FY 2025, while quarterly EPS moved between a US$0.49 loss and US$0.24. This set the scene for a year that turned profitable on a trailing basis despite a softer fourth quarter. For investors, the mix...
NasdaqGS:AMBA
NasdaqGS:AMBASemiconductor

Ambarella (AMBA) Quarterly Losses Persist And Reinforce Skeptical Profitability Narratives

Ambarella (AMBA) has just closed out FY 2026 with fourth quarter revenue of US$100.9 million and a basic EPS loss of US$0.38, set against trailing twelve month revenue of US$390.7 million and a TTM EPS loss of US$1.78. Over the past six reported quarters, the company has seen quarterly revenue range from US$82.7 million to US$108.5 million while basic EPS losses have moved between US$0.35 and US$0.58. This gives investors a clear view of how growth ambitions are currently weighing on the...
NYSE:GIC
NYSE:GICTrade Distributors

Is Earnings Beat And Higher Dividend Altering The Investment Case For Global Industrial (GIC)?

Global Industrial Company recently reported fourth-quarter 2025 sales of US$345.6 million and net income of US$14.6 million, alongside full-year 2025 sales of US$1.38 billion and net income of US$72.1 million, and raised its quarterly dividend by 7.7% to US$0.28 per share. The combination of higher sales, improved earnings per share, an eleventh consecutive annual dividend increase, and ongoing share repurchases highlights management’s focus on cash generation and shareholder returns while...
NYSE:MEG
NYSE:MEGCommercial Services

Is It Too Late To Consider Montrose Environmental Group (MEG) After Its Recent Share Price Surge?

Wondering if Montrose Environmental Group at around US$29.22 is offering fair value today, or if the recent excitement has already been priced in? The stock has logged returns of 26.5% over the last 7 days, 30.2% over the last 30 days, 17.4% year to date and 50.4% over the last year, while the 3 year and 5 year returns sit at 21.4% and 28.6% declines. This price action comes as investors continue to assess Montrose Environmental Group's position in environmental services and its execution on...
NasdaqGS:KDP
NasdaqGS:KDPBeverage

A Look At Keurig Dr Pepper (KDP) Valuation After Recent Share Price Momentum

Why Keurig Dr Pepper is on investors’ radar today Keurig Dr Pepper (KDP) has drawn attention after recent share price moves, with the stock showing gains over the past week, month, and past 3 months that contrast with weaker one year returns. See our latest analysis for Keurig Dr Pepper. The recent 30 day share price return of 13.37% and 90 day share price return of 8.53% sit against a 1 year total shareholder return of a 6.83% decline. This suggests momentum has picked up lately after a...
NYSE:ESRT
NYSE:ESRTOffice REITs

Is Empire State Realty Trust (ESRT) Pricing Reflect Long-Term Office Demand Concerns?

If you are wondering whether Empire State Realty Trust's current share price reflects its true worth, you are not alone. This article will walk through what the numbers are actually saying about value. The stock last closed at US$5.88, with returns of 0.8% decline over 7 days, 9.8% decline over 30 days, 9.1% decline year to date and 35.4% decline over 1 year. This naturally raises questions about whether the market is reassessing its risks or overlooking potential. Recent coverage around...
NYSE:NRP
NYSE:NRPOil and Gas

Is It Time To Reassess Natural Resource Partners (NRP) After Its Multi Year Rally

If you are looking at Natural Resource Partners and wondering whether the current price reflects its true value, this article will walk you through what the numbers are really saying. The stock closed at US$121.05, with returns of a 1.8% decline over 7 days, 6.0% over 30 days, 16.4% year to date, 19.6% over 1 year and a very large gain over 5 years. This naturally raises questions about how the current price stacks up against fundamentals. Recent interest in Natural Resource Partners has...
NasdaqGS:FIGR
NasdaqGS:FIGRConsumer Finance

Figure Technology Solutions (FIGR) 31% Net Margin Reinforces Bullish Profitability Narrative

Figure Technology Solutions (FIGR) FY 2025 Earnings Snapshot Figure Technology Solutions (FIGR) has capped FY 2025 with Q4 revenue of US$135.6 million and basic EPS of US$0.07, alongside trailing twelve month revenue of US$432.1 million and EPS of US$1.17 that put the latest figures into a fuller context. The company has seen quarterly revenue move from US$67.9 million in Q1 2025 to US$90.0 million in Q2, US$138.5 million in Q3 and US$135.6 million in Q4, while basic EPS has ranged from a...
NYSE:BFLY
NYSE:BFLYMedical Equipment

Assessing Butterfly Network’s Valuation After Record Q4 Growth And First Positive Operating Cash Flow

Butterfly Network (BFLY) is back on investors’ radar after reporting record fourth quarter revenue, 41% year-over-year growth and its first quarter of positive operating cash flow, supported by its Butterfly Embedded platform and Midjourney partnership. See our latest analysis for Butterfly Network. The share price has been volatile around the recent earnings and guidance, with a 27.18% 7 day share price return reversing sharply into an 18.84% 1 day decline. At the same time, the 1 year total...
NasdaqCM:ABTC
NasdaqCM:ABTCSoftware

American Bitcoin (ABTC) Revenue Surge With FY 2025 Loss Tests Bullish Growth Narratives

American Bitcoin (ABTC) has closed out FY 2025 with Q4 revenue of US$78.3 million and a basic EPS loss of US$0.06, alongside trailing twelve month revenue of US$185.2 million and EPS of US$0.17. Over the past few quarters the company has seen revenue move from US$11.6 million in Q3 2024 to US$12.3 million in Q1 2025, US$30.3 million in Q2 2025, US$64.2 million in Q3 2025 and US$78.3 million in Q4 2025, while quarterly EPS has ranged from a loss of US$1.99 in Q1 2025 to a profit of US$0.06 in...
NasdaqGS:MNST
NasdaqGS:MNSTBeverage

Monster Beverage (MNST) Margin Expansion Reinforces Bull Narratives Despite Rich P/E

Monster Beverage (MNST) closed out FY 2025 with fourth quarter revenue of US$2.1 billion and basic EPS of US$0.46, alongside trailing twelve month revenue of US$8.3 billion and EPS of US$1.95 that followed earnings growth of 26.3% over the last year. Over recent periods, the company has seen quarterly revenue move from US$1.9 billion in Q3 2024 to US$2.0 billion in Q4 2024, then to US$1.9 billion in Q1 2025 and US$2.1 billion in both Q2 and Q4 2025, while basic EPS shifted from US$0.38 in Q3...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Ionis FDA And Phase 3 Updates Reframe Rare Disease Valuation Story

Ionis Pharmaceuticals (NasdaqGS:IONS) received FDA Priority Review for olezarsen in severe hypertriglyceridemia, indicating an expedited regulatory timeline. New Phase 3 analyses for DAWNZERA, an RNA targeted therapy for hereditary angioedema, are scheduled for presentation at a major scientific forum. These developments focus on two rare disease programs that are central to Ionis’s drug development efforts. Ionis Pharmaceuticals focuses on RNA targeted medicines, with a portfolio that...
NYSE:BRSL
NYSE:BRSLHospitality

Brightstar Lottery Board Shifts Test Capital Returns And Italy Growth Plan

Brightstar Lottery (NYSE:BRSL) has appointed Mariangela Zappia, an international diplomat, as an independent director to its board. The company has announced that CFO Max Chiara will not stand for board re election, with his departure expected after the upcoming shareholder meeting. Brightstar recently secured a nine year renewal of the Italy Lotto licence, supporting a multiyear capital allocation plan and expansion initiatives. Brightstar Lottery, listed on the NYSE under ticker BRSL,...
NYSE:ESTC
NYSE:ESTCSoftware

Elastic ESTC Swings To Q3 Profit Challenging Persistent Loss Making Narrative

Q3 2026 results set up a cleaner earnings story for Elastic (ESTC) Elastic (ESTC) has just posted Q3 2026 revenue of US$449.9 million with basic EPS of US$0.07, alongside trailing twelve month revenue of about US$1.7 billion and a basic EPS loss of US$0.80, giving investors a clearer read on both recent momentum and the still negative full year earnings base. The company has seen quarterly revenue move from US$365.4 million in Q2 2025 to US$449.9 million in Q3 2026, while basic EPS has...
NYSE:BURL
NYSE:BURLSpecialty Retail

Burlington’s 2026 Expansion Plans Test Valuation And Debt Profile

Burlington Stores (NYSE:BURL) plans to open 110 net new stores in 2026, ahead of earlier expectations. The company is also expanding its corporate office footprint in New York to support a larger organization. These moves reflect management's intent to scale operations and reinforce Burlington's long term growth plans. Burlington Stores comes into this announcement with its shares at $306.62 and a 1 year return of 23.0%. Over 3 years the stock has returned 41.8%, and over 5 years 9.8%,...
NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

AbCellera (ABCL) Is Up 18.8% After Pivoting To Clinical Stage And Filing Share Offering

AbCellera Biologics Inc. has reported its full-year 2025 results, with revenue rising to US$75.13 million and net loss easing to US$146.41 million, while also filing a US$45.54 million shelf registration for 15,030,034 common shares tied to an employee share offering. Alongside these financials, AbCellera’s shift into a clinical-stage biotech with advancing programs ABCL635 and ABCL575 and a nearly completed manufacturing facility signals a business model increasingly centered on internal...
NYSE:ARLO
NYSE:ARLOElectronic

Arlo Technologies (ARLO) Earnings Turn Positive Challenging Skeptical Profitability Narratives

Arlo Technologies (ARLO) closed out FY 2025 with Q4 revenue of US$141.3 million and basic EPS of US$0.05, alongside net income of US$5.8 million. The trailing 12 month line shows revenue of US$529.3 million and basic EPS of US$0.14 as the business moves further into consistent profitability. Over the past six quarters, the company has seen revenue range from US$119.1 million to US$141.3 million per quarter, with basic EPS shifting from a loss of US$0.05 in late 2024 to positive contributions...
NYSE:HLX
NYSE:HLXEnergy Services

Helix Energy Solutions Group (HLX) Valuation After Record Q4 Revenue And New Multiyear Contract Wins

Helix Energy Solutions Group (HLX) is back in focus after reporting its highest fourth quarter revenue since 2013, positive free cash flow, and year end cash and liquidity that support recently secured multiyear contracts. See our latest analysis for Helix Energy Solutions Group. Those results come after a busy period, with Helix Energy Solutions Group reporting full year 2025 earnings, recording a US$18.06 million long lived asset impairment, completing its share repurchase program, and...
NasdaqGM:ODD
NasdaqGM:ODDPersonal Products

Is Oddity Tech (ODD) Now An Opportunity After A 70% Year To Date Share Price Fall

If you are wondering whether Oddity Tech is now a bargain or a value trap, a closer look at how its current share price lines up with its fundamentals can help frame that question. The stock has seen large price swings recently, with a 7 day return of 63.2% decline, a 30 day return of 64.8% decline, and a year to date return of 70.2% decline, while the 1 year return sits at 75.3% decline from the current last close of US$11.77. These moves have prompted renewed attention on the business, as...